Biomed pharmaceuticals winstrol

Funding and performing translational research – models in taking bench side research to market. (Collaboration with the IIA; Horizon 2020; NIH; Spark (Stanford) programs)
Moderator : Gil Granot-Mayer, CEO, YEDA
Michael Salgaller , Supervisor, Invention Development and Marketing Unit (IDMU), Technology Transfer Center, National Cancer Institute, National Institutes of Health
Pasi Sorvisto , Director, SPARK Finland Program
Esther Hagai, CEO, FutuRx
Prof. Eli Hazum, Head, IDEA program at YEDA
Aviv Zeevi Balasiano, VP, Head of Division – Technology Infrastructure Israel Innovation Authority
Eyal Zimlichman, Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center

Members of BioMed Valley Discoveries attended the 2015  American Association for Cancer Research  (AACR) Annual Meeting in Philadelphia, PA. The following abstract was presented by Dean Welsch, PhD: Germann U, Furey B, Roix J, Markland W, Hoover R, Aronov A, Hale M, Chen G, Martinez-Botella G, Alargova R, Fan B, Sorrell D, Meshaw K, Shapiro P, Wick MJ, Benes C, Garnett M, DeCrescenzo G, Namchuk M, Saha S, Welsch DJ. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; 2015. Abstract nr 4693.  Abstract |  Presentation

Biomed pharmaceuticals winstrol

biomed pharmaceuticals winstrol


biomed pharmaceuticals winstrolbiomed pharmaceuticals winstrolbiomed pharmaceuticals winstrolbiomed pharmaceuticals winstrolbiomed pharmaceuticals winstrol